- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
4
High Growth Stocks
4 companies
Zevra Therapeutics
Market Cap: US$720.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.89
7D
6.4%
1Y
25.0%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$25.35
7D
-3.2%
1Y
58.6%
Kiniksa Pharmaceuticals International
Market Cap: US$6.1b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$78.47
7D
2.2%
1Y
132.5%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.22
7D
1.1%
1Y
20.7%